L-DOPA AND (-)-DEPRENIL IN TREATMENT OF PARKINSONS-DISEASE - LONG-TERM STUDY

被引：0
作者：
AMBROZI, L
BIRKMAYER, W
RIEDERER, P
YOUDIM, MBH
机构：
[1] RADCLIFFE INFIRM,MRC CLIN PHARMACOL UNIT,OXFORD OX2 6HE,ENGLAND
[2] LUDWIG BOLTZMANN NEUROCHEM INST,A-1130 VIENNA,AUSTRIA
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1976年 / 58卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P423 / P423
页数：1
相关论文
共 6 条
[1]   MODERN TREATMENT OF PARKINSONISM [J].
BIRKMAYER, W ;
NEUMAYER, E .
ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04) :257-+
[2]  
BIRKMAYER W, 1974, WIEN MED WOCHENSCHR, V124, P340
[3]   POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].
BIRKMAYER, W ;
RIEDERER, P ;
YOUDIM, MBH ;
LINAUER, W .
JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326
[4]   COMPARISON OF PHARMACOLOGICAL AND BIOCHEMICAL PROPERTIES OF SUBSTRATE-SELECTIVE MONOAMINE-OXIDASE INHIBITORS [J].
CHRISTMA.AJ ;
COULSON, CJ ;
RIDDELL, D ;
MAXWELL, DR .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 45 (03) :490-&
[5]  
Fuxe K, 1970, AMPHETAMINES RELATED, P257
[6]  
KNOLL J, 1965, ARCH INT PHARMACOD T, V155, P154
1